SEC Form 4 · accession 0000899243-19-006233

ARVINAS, INC. · ARVN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — See Remarks

Period of report

Mar 1, 2019

Accepted (ET)

Mar 5, 2019 · 6:28 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001655759

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F2	—	Mar 1, 2019	A	10,734	A	—	—	Common Stock	10,734	10,734	D
Stock Option (right to buy)^F3	$19.36	Mar 1, 2019	A	60,745	A	—	Feb 28, 2029	Common Stock	60,745	60,745	D
Restricted Stock Units^F4,F5	—	Mar 1, 2019	A	776	A	—	—	Common Stock	776	776	I
Stock Option (right to buy)^F6	$19.36	Mar 1, 2019	A	1,924	A	—	Feb 28, 2029	Common Stock	1,924	1,924	I

F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2The restricted stock units vest in four equal annual installments beginning March 1, 2020.
F3This option award was granted on March 1, 2019. 1/4 of the shares underlying the award shall vest on March 1, 2020, with the remainder of the shares vesting in equal monthly installments following March 1, 2020 through March 1, 2023.
F4Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F5The restricted stock units vest in four equal annual installments beginning March 1, 2020.
F6This option award was granted on March 1, 2019. 1/4 of the shares underlying the award shall vest on March 1, 2020, with the remainder of the shares vesting in equal monthly installments following March 1, 2020 through March 1, 2023.

Senior Vice President, Chemistry